FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Prograf (tacrolimus) filed by Astellas Pharma US, Inc. The action updates the labeling to reflect new or revised…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Pancreas Transplant Rejection

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

SUPPL AP for PROGRAF (TACROLIMUS)